PUBLICATIONS · 26304886
Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2015 Nov 1
- First author
- Leonard JP
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Leonard JP
- type
- Author
- name
- Jung SH
- type
- Author
- name
- Johnson J
- type
- Author
- name
- Pitcher BN
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Blum KA
- type
- Author
- name
- Czuczman M
- type
- Author
- name
- Giguere JK
- type
- Author
- name
- Cheson BD
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Leonard JP
- type
- Author
- name
- Jung SH
- type
- Author
- name
- Johnson J
- type
- Author
- name
- Pitcher BN
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Blum KA
- type
- Author
- name
- Czuczman M
- type
- Author
- name
- Giguere JK
- type
- Author
- name
- Cheson BD
- type
- Author
- bibliography ids
- nci-bib-b4d717e4dad9c516a919ac6b
- book metadata
- content sha256
- 03331610d389e12d56eb4ae6436621c5b16979d34a7bcfc27dfdb3ee68c4f924
- document type
- citation
- dois
- 10.1200/JCO.2014.59.9258
- electronic publication date
- display
- 2015 Aug 24
- precision
- day
- year
- 2015
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:26304886
- immutable id
- pubmed:26304886@03331610d389e12d56eb4ae6436621c5b16979d34a7bcfc27dfdb3ee68c4f924
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 31
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3635-40
- volume
- 33
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 26304886
- provenance
- batch id
- 4c1ece5bfc3d8e2be622
- provider
- NCBI PubMed ESummary
- record sha256
- 908a1bd3b63a1ae70136f3d10f4af10eedf65878f4d657dbde6b5ae2b45fe7b7
- response sha256
- 85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
- retrieved at
- 2026-09-09T23:47:12.730551+00:00
- publication date
- display
- 2015 Nov 1
- precision
- day
- year
- 2015
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle